Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease.
Article Details
- CitationCopy to clipboard
Bolscher BG, de Boer M, de Klein A, Weening RS, Roos D
Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease.
Blood. 1991 Jun 1;77(11):2482-7.
- PubMed ID
- 1710153 [ View in PubMed]
- Abstract
The NADPH:O2 oxidoreductase of phagocytic leukocytes is an important enzyme for the bactericidal activity of these cells. Cytochrome b558 is a membrane component of this enzyme. In X-linked chronic granulomatous disease (Xb- CGD) the phagocytes are defective in the beta-subunit (gp91-phox) of this cytochrome. We have studied the genetic defect in a group of six X-linked CGD patients characterized by complete or partial loss of cytochrome b558 with the use of the polymerase chain reaction. All patients had a different single point mutation in the gp91-phox gene, indicating that the genetic defect in Xb- CGD is very heterogeneous. In one patient the mutation leads to a premature termination codon. In the other five cases these mutations predict incorporation of a different amino acid. The mutations were with one exception found in the N-terminal half of the protein, suggesting that this part of cytochrome b558 is important for the binding of the heme or for formation of a stable complex with p22-phox. Two histidyl residues were found that might be ligands of the heme iron.